NRx Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | 05/18/2021 | 7,149 | $253,000 | 100.00% | 0.02% |
| MORGAN STANLEY | 05/17/2021 | 670 | $24,000 | -50.70% | 0.00% |
| WEALTHCARE ADVISORY PARTNERS LLC | 04/30/2021 | 375 | $13,000 | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/13/2021 | 350 | $12,000 | -30.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/17/2021 | 100 | $4,000 | 100.00% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 05/13/2021 | 0 | $0 | 0.00% | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 05/13/2021 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 05/17/2021 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 05/12/2021 | 0 | $0 | -100.00% | 0.00% |
NRx Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 3 institutional investors and hedge funds held shares of NRx Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Bluefin Trading, LLC: 87,900
VERTEX ONE ASSET MANAGEMENT INC.: 100,000
COWEN INC.: 0
0.03% of NRx Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 187,900 shares in the last 24 months. This purchase volume represents approximately $266,818 in transactions.